ALREXPRO.COM: Keyword Density Checker

Total words: 1523 | 2-word phrases: 397 | 3-word phrases: 431 | 4-word phrases: 444

PAGE INFO

Title	Try to keep the title under 60 characters (75 characters) ALREX® Loteprednol Etabonate Ophthalmic Suspension, Bausch + Lomb
Description	Try to keep the meta description between 50 - 160 characters (239 characters) ALREX® (loteprednol etabonate ophthalmic suspension) 0.2% for ocular signs and symptoms of acute seasonal allergic conjunctivitis, acute SAC, seasonal allergic conjunctivitis, ocular allergies, eye drops, corticosteroid, antihistamine
Keywords	Meta keywords are not recommended anymore (239 characters) ALREX, SAC, seasonal allergic conjunctivitis, allergies, ocular, acute SAC, ocular allergies, eye drops, corticosteroid, antihistamine
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	alrex is a	4	0.93%
2	ophthalmic suspension 02	4	0.93%
3	signs and symptoms	3	0.70%
4	diseases of the	3	0.70%
5	samples patient copay	3	0.70%
6	request samples patient	3	0.70%
7	of the cornea	3	0.70%
8	prolonged use of	3	0.70%
9	foreign body sensation	3	0.70%
10	damage defects in	2	0.46%
11	defects in visual	2	0.46%
12	secondary ocular infections	2	0.46%
13	nerve damage defects	2	0.46%
14	in visual acuity	2	0.46%
15	information for alrex	2	0.46%
16	prescribing information for	2	0.46%
17	optic nerve damage	2	0.46%
18	longer intraocular pressure	2	0.46%
19	full prescribing information	2	0.46%
20	ocular infections exacerbation	2	0.46%
21	infections exacerbation or	2	0.46%
22	warnings and precautions	2	0.46%
23	for full prescribing	2	0.46%
24	prolongation of viral	2	0.46%
25	here for full	2	0.46%
26	click here for	2	0.46%
27	ocular infections including	2	0.46%
28	infections including herpes	2	0.46%
29	including herpes simplex	2	0.46%
30	herpes simplex delay	2	0.46%

#	Keyword	Frequency	Density
1	request samples patient copay	3	0.68%
2	intraocular pressure should be	2	0.45%
3	ophthalmic suspension 0205 in	2	0.45%
4	temporary relief of the	2	0.45%
5	alrex is also contraindicated	2	0.45%
6	is also contraindicated in	2	0.45%
7	in clinical studies included	2	0.45%
8	is indicated for the	2	0.45%
9	02 is indicated for	2	0.45%
10	suspension 02 is indicated	2	0.45%
11	ophthalmic suspension 02 is	2	0.45%
12	etabonate ophthalmic suspension 02	2	0.45%
13	0205 in clinical studies	2	0.45%
14	suspension 0205 in clinical	2	0.45%
15	individuals with known or	2	0.45%
16	suspected hypersensitivity to any	2	0.45%
17	signs and symptoms of	2	0.45%
18	hypersensitivity to any of	2	0.45%
19	to any of the	2	0.45%
20	patients treated with loteprednol	2	0.45%
21	of patients treated with	2	0.45%
22	515 of patients treated	2	0.45%
23	in 515 of patients	2	0.45%
24	occurring in 515 of	2	0.45%
25	preparation and to other	2	0.45%
26	and to other corticosteroids	2	0.45%
27	to other corticosteroids prolonged	2	0.45%
28	of corticosteroids ocular adverse	2	0.45%
29	epiphora foreign body sensation	2	0.45%
30	structures alrex is also	2	0.45%
31	and symptoms of seasonal	2	0.45%
32	prolonged use of corticosteroids	2	0.45%
33	the cornea and conjunctiva	2	0.45%
34	foreign body sensation itching	2	0.45%
35	body sensation itching injection	2	0.45%
36	sensation itching injection and	2	0.45%
37	dendritic keratitis vaccinia and	2	0.45%
38	keratitis dendritic keratitis vaccinia	2	0.45%
39	itching injection and photophobia	2	0.45%
40	click here for full	2	0.45%

#	URL	Whois	Check
1	https://www.bauschaccessprogram.com/	Whois	bauschaccessprogram.com
2	https://bauschlomb.mysamplecloset.com/login	Whois	mysamplecloset.com
3	https://www.bauschaccessprogram.com/	Whois	bauschaccessprogram.com
4	https://bauschlomb.mysamplecloset.com/login	Whois	mysamplecloset.com
5	https://www.bauschaccessprogram.com/	Whois	bauschaccessprogram.com
6	https://www.bausch.com/terms/	Whois	bausch.com
7	https://www.bausch.com/privacy/	Whois	bausch.com
8	https://pi.bausch.com/globalassets/pdf/PackageInserts/Pharma/alrex-package-insert.pdf	Whois	bausch.com
9	https://bauschlomb.mysamplecloset.com/login	Whois	mysamplecloset.com
10	https://www.bauschaccessprogram.com/	Whois	bauschaccessprogram.com
11	https://www.bausch.com/terms/	Whois	bausch.com
12	https://www.bausch.com/privacy/	Whois	bausch.com
13	https://www.bausch.com/	Whois	bausch.com
14	http://cloud.marketing.bausch.com/Privacy-Page-Unsubscribe	Whois	bausch.com
15	https://cloud.marketing.bausch.com/do-not-sell-or-share	Whois	bausch.com
16	https://cloud.marketing.bausch.com/do-not-target	Whois	bausch.com
17	https://cloud.marketing.bausch.com/Limit-Sensitive-Personal-Information-Usage	Whois	bausch.com
18	https://submit-irm.trustarc.com/services/validation/57c4f658-fcc9-4285-a079-28407529c706	Whois	trustarc.com
19	https://pi.bausch.com/globalassets/pdf/PackageInserts/Pharma/alrex-package-insert.pdf	Whois	bausch.com
20	https://www.bausch.com/our-products/rx-pharmaceutical/alrex-loteprednol-etabonate-ophthalmic-suspension-02	Whois	bausch.com